William H Sharfman

Publication Activity (10 Years)

Years Active: 2021-2024
Publications (10 Years): 5

Top Topics

Epidermal Growth Factor Receptor

Drug Administration

Ejection Fraction

Top Venues

Journal of clinical oncology : official journal of the American Society of Clinical Oncology

Cancer biology & therapy

This page only lists publications with an associated author ORCID identifier.

Publications

Kara M Schenk, Julie Stein Deutsch, Sunandana Chandra, Diwakar Davar, Zeynep Eroglu, Nikhil I Khushalani, Jason John Luke, Patrick A Ott, Jeffrey A Sosman, Vikram Aggarwal, Megan D Schollenberger, William H Sharfman, Kristin P Bibee, Jeffrey F Scott, Manisha J Loss, Hao Wang, Hanfei Qi, Elad Sharon, Howard Streicher, Helen X Chen, Robert N Woodward, Serena M Bagnasco, Janis M Taube, Suzanne L Topalian, Daniel C Brennan, Evan J Lipson
Nivolumab + Tacrolimus + Prednisone ± Ipilimumab for Kidney Transplant Recipients With Advanced Cutaneous Cancers. Journal of clinical oncology : official journal of the American Society of Clinical Oncology 42 (9) (2024)
Kara M Schenk, Julie Stein Deutsch, Sunandana Chandra, Diwakar Davar, Zeynep Eroglu, Nikhil I Khushalani, Jason John Luke, Patrick A Ott, Jeffrey A Sosman, Vikram Aggarwal, Megan D Schollenberger, William H Sharfman, Kristin P Bibee, Jeffrey F Scott, Manisha J Loss, Hao Wang, Hanfei Qi, Elad Sharon, Howard Streicher, Helen X Chen, Robert N Woodward, Serena M Bagnasco, Janis M Taube, Suzanne L Topalian, Daniel C Brennan, Evan J Lipson
Nivolumab + Tacrolimus + Prednisone ± Ipilimumab for Kidney Transplant Recipients With Advanced Cutaneous Cancers. Journal of clinical oncology : official journal of the American Society of Clinical Oncology 42 (9) (2024)
Kara M Schenk, Julie Stein Deutsch, Sunandana Chandra, Diwakar Davar, Zeynep Eroglu, Nikhil I Khushalani, Jason John Luke, Patrick A Ott, Jeffrey A Sosman, Vikram Aggarwal, Megan D Schollenberger, William H Sharfman, Kristin P Bibee, Jeffrey F Scott, Manisha J Loss, Hao Wang, Hanfei Qi, Elad Sharon, Howard Streicher, Helen X Chen, Robert N Woodward, Serena M Bagnasco, Janis M Taube, Suzanne L Topalian, Daniel C Brennan, Evan J Lipson
Nivolumab + Tacrolimus + Prednisone ± Ipilimumab for Kidney Transplant Recipients With Advanced Cutaneous Cancers. Journal of clinical oncology : official journal of the American Society of Clinical Oncology (2024)
Tasha Hughes, Matthew Klairmont, William H Sharfman, Howard L Kaufman
Interleukin-2, Ipilimumab, and Anti-PD-1: clinical management and the evolving role of immunotherapy for the treatment of patients with metastatic melanoma. Cancer biology & therapy (2021)
Merve Hasanov, Denái R Milton, William H Sharfman, Bret Taback, Lee D Cranmer, Gregory A Daniels, Lawrence Flaherty, Sigrun Hallmeyer, Mohammed M Milhem, Lynn G Feun, Ralph J Hauke, Gary Doolittle, Nancy Gregory, Sapna Pradyuman Patel
An Open-Label, Randomized, Multi-Center Study Comparing the Sequence of High Dose Aldesleukin (Interleukin-2) and Ipilimumab (Yervoy) in Patients with Metastatic Melanoma. Oncoimmunology 10 (1) (2021)